Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover Trial

This publication has 29 references indexed in Scilit:

• Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer
  JAMA Oncology, 2021
• A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer
  European Urology, 2021
• Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site
  JAMA Oncology, 2015
• A Genomic Classifier Improves Prediction of Metastatic Disease Within 5 Years After Surgery in Node-negative High-risk Prostate Cancer Patients Managed by Radical Prostatectomy Without Adjuvant Therapy
  European Urology, 2015
• Combined Value of Validated Clinical and Genomic Risk Stratification Tools for Predicting Prostate Cancer Mortality in a High-risk Prostatectomy Cohort
  European Urology, 2015
• Genomic Prostate Cancer Classifier Predicts Biochemical Failure and Metastases in Patients After Postoperative Radiation Therapy
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
• Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96–02/AUO AP 09/95 Trial
  European Urology, 2014
• EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
  European Urology, 2014
• The CAPRA‐S score
  Cancer, 2011
• Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial
  Journal of Urology, 2009